Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives $18.62 Average Price Target from Analysts

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been assigned a consensus recommendation of “Hold” from the fifteen brokerages that are covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $18.6154.

Several research analysts have recently weighed in on ACHC shares. KeyCorp lowered their target price on Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a report on Wednesday, December 3rd. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Royal Bank Of Canada reduced their price target on Acadia Healthcare from $19.00 to $17.00 and set an “outperform” rating on the stock in a report on Wednesday, January 14th. Leerink Partners lowered shares of Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 3rd. Finally, Raymond James Financial set a $17.00 target price on shares of Acadia Healthcare in a research note on Wednesday, December 3rd.

Acadia Healthcare Trading Down 0.4%

Shares of ACHC stock opened at $13.37 on Friday. Acadia Healthcare has a fifty-two week low of $11.43 and a fifty-two week high of $43.58. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.44 and a current ratio of 1.44. The stock’s fifty day moving average is $14.03 and its two-hundred day moving average is $18.97. The firm has a market capitalization of $1.23 billion, a P/E ratio of 11.43, a PEG ratio of 3.82 and a beta of 0.89.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. The business had revenue of $851.57 million during the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a net margin of 3.29% and a return on equity of 7.66%. The company’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.91 earnings per share. Research analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in Acadia Healthcare in the first quarter valued at $1,600,000. Goldman Sachs Group Inc. raised its holdings in Acadia Healthcare by 21.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock valued at $21,170,000 after buying an additional 121,444 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Acadia Healthcare by 8.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock valued at $10,337,000 after buying an additional 27,207 shares during the last quarter. Public Employees Retirement System of Ohio boosted its stake in Acadia Healthcare by 2.6% during the second quarter. Public Employees Retirement System of Ohio now owns 30,468 shares of the company’s stock worth $691,000 after buying an additional 760 shares during the period. Finally, Signaturefd LLC increased its position in shares of Acadia Healthcare by 1,451.7% during the second quarter. Signaturefd LLC now owns 5,043 shares of the company’s stock valued at $114,000 after acquiring an additional 4,718 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.